The DOI matches its Crossref record.
Angiotensin II and alpha-adrenergic agonists inhibit rat liver adenylate cyclase.
Open accessAbstract
Rat liver membranes were prepared according to a modified version of Neville's procedure ((1968) Biochin.Biophys.Acta 154, 540-552), and 5 mM EDTA was present at ail steps of the preparation.This type of preparation exhibited a GTP-dependent increase in adenylate cyclase activity in the presence of monovalent cations (Li' > Na' > K+).L-Epinephrine (100 p ~, in the presence of a P-adrenergic blocking agent) and Asn'-Val5-angiotensin 11 (1-100 n ~) inhibited the GTP plus ion-stimulated adenylate cyclase in a dose-dependent and not additive manner.But up to 1 PM, vasopressin did not inhibit the enzyme neither did it block the inhibitory effects of 1-epinephrine and angiotensin 11.Unlike prazosin, phentolamine, phenoxybenzamine, and yohimbine blocked adenylate cyclase inhibition by 1-epinephrine but did not affect that induced by angiotensin 11.This demonstrated that 1-epinephrine inhibited rat liver adenylate cyclase through an a-type of adrenoceptor different from the receptor mediating the angiotensin TI effect.Inhibition by angiotensin I1 was blocked by sarcosine'-1le"-angiotensin 11, a known competitive inhibitor of angiotensin 11.It is concluded from the present study that, of the three glycogenolytic agents tested, &epinephrine, angiotensin 11, and vasopressin, only Z-epinephrine and angiotensin II inhibit rat liver adenylate cyclase.These results, combined with the observation that the effect of epinephrine is mediated through an a & p e of adrenoceptor whereas phosphorylase activation by epinephrine is mediated through an crl-type, suggest that the observed inhibition of adenylate cyclase by epinephrine and angiotensin I1 is not directly related to the effects of these hormones on phosphorylase activation.' F. Assimacopoulos and E. H. Exton, personal communication.inhibition, respectively, were clearly different from each other suggests that the adenylate cyclase inhibition by angiotensin
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Receptor-effector coupling by G proteins
Birnbaumer, L., Abramowitz, J., & Brown, A. M. (1990) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(90)90007-y · Cited by 1,118
Creba, J. A., Downes, C. P., Hawkins, P. T., Brewster, G., Michell, R. H., & Kirk, C. J. (1983) · Biochemical Journal · doi:10.1042/bj2120733 · Cited by 552
Angiotensin receptors: distribution, signalling and function
DINH, D. T., FRAUMAN, A. G., JOHNSTON, C. I., & FABIANI, M. E. (2001) · Clinical Science · doi:10.1042/cs1000481 · Cited by 268
Angiotensin Receptors and Their Therapeutic Implications
Greindling, K. K., Lassegue, B., & Alexander, R. W. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.001433 · Cited by 262
Bottari, S. P., King, I. N., Reichlin, S., Dahlstroem, I., Lydon, N., & de Gasparo, M. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91629-5 · Cited by 252
Metadata
- Authors
- Jard, S., Cantau, B., & Jakobs, K. H.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1981-03
- Volume
- 256
- Issue
- 6
- Pages
- 2603-2606
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1780180651
- Cited by
- 186
- References
- 0
- FWCI
- 10.66
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Angiotensin II and alpha-adrenergic agonists inhibit rat liver adenylate cyclase. https://app.cochat.ai/papers/10.1016/s0021-9258(19)69653-5
- The paper
- Jard, S., Cantau, B., & Jakobs, K. H. (1981). Angiotensin II and alpha-adrenergic agonists inhibit rat liver adenylate cyclase. Journal of Biological Chemistry. https://doi.org/10.1016/s0021-9258(19)69653-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.